Microbiology & Infectious Diseases

New findings indicate that a two-dose primary schedule without booster can provide sufficient protection in high-transmission, resource-limited settings.

This is the first real-world evidence that expanded prophylactic antibiotic use can reduce community transmission of iGAS.

Preliminary surveillance data from Argentina’s national maternal RSV vaccination programme show a marked reduction in infant hospitalisations during the 2024 RSV season.

New data from a large paediatric cohort suggest that cell-based influenza vaccines provide improved protection over egg-based formulations.

A comparison of national RSV prevention strategies has shown that monoclonal antibody immunisation in Spain was vastly more effective than maternal vaccination in the UK.

UK scientists have detected traces of West Nile virus in mosquitoes for the first time, though experts stress that the risk to the public remains very low.

England is set to become the first country in the world to roll out a national vaccination programme against gonorrhoea, aiming to curb record-high infection rates and growing antibiotic resistance.

A new study provides strong evidence supporting the use of dolutegravir and TAF-emtricitabine for second-line antiretroviral therapy in children.